1-193122202-T-A
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PM2
The NM_024529.5(CDC73):c.2T>A(p.Met1?) variant causes a start lost change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_024529.5 start_lost
Scores
Clinical Significance
Conservation
Publications
- hyperparathyroidism 2 with jaw tumorsInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, ClinGen
- hyperparathyroidism 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- parathyroid gland carcinomaInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- familial isolated hyperparathyroidismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_024529.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CDC73 | TSL:1 MANE Select | c.2T>A | p.Met1? | start_lost | Exon 1 of 17 | ENSP00000356405.4 | Q6P1J9 | ||
| CDC73 | c.2T>A | p.Met1? | start_lost | Exon 2 of 18 | ENSP00000628368.1 | ||||
| CDC73 | c.2T>A | p.Met1? | start_lost | Exon 1 of 17 | ENSP00000628369.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at